SEC Form D filing

Canton Strategic Holdings, Inc., 2026-04-15

An SEC Form D private-offering notice from Red Bank, NJ, a $1,740,000 filer-stated offering target in Biotech. Filed 2026-04-15. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Canton Strategic Holdings, Inc. site↗ Verified via SEC Form D

Nasdaq listed company, formerly Tharimmune, that combines clinical stage biotech research in inflammation and immunology with a digital asset treasury strategy built around the Canton Network.

Filed 2026-04-15Filed to raise $1,740,000First money in 2025-07-23Raised so far $1,740,000HQ (as filed) Red Bank, NJSector Biotech web-verified against the company’s own siteStage (inferred) Seed
Source linked the Form D on EDGAR↗Website verified cantonstrategic.com↗Named in the filing 10 executives & directors
Open this row on the live feed →More new filings in New Jersey →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Also filed for this raise

every source Form D behind this opportunity
  • Canton Strategic Holdings, Inc., 2026-04-15, $1.7M EDGAR↗
  • Canton Strategic Holdings, Inc., 2026-04-15, $1.2M EDGAR↗

Other Form D filings from the same week

each with its own page and its own EDGAR source